COOPER COS INC/THE (COO)

US2166485019 - Common Stock

92.39  -2.1 (-2.22%)

After market: 92.39 0 (0%)

Fundamental Rating

5

Overall COO gets a fundamental rating of 5 out of 10. We evaluated COO against 187 industry peers in the Health Care Equipment & Supplies industry. COO scores excellent on profitability, but there are some minor concerns on its financial health. COO has a valuation in line with the averages, but it does not seem to be growing.



7

1. Profitability

1.1 Basic Checks

In the past year COO was profitable.
COO had a positive operating cash flow in the past year.
COO had positive earnings in 4 of the past 5 years.
Of the past 5 years COO 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of COO (2.97%) is better than 75.94% of its industry peers.
The Return On Equity of COO (4.53%) is better than 75.94% of its industry peers.
COO has a better Return On Invested Capital (4.38%) than 75.94% of its industry peers.
COO had an Average Return On Invested Capital over the past 3 years of 4.13%. This is below the industry average of 8.20%.
The 3 year average ROIC (4.13%) for COO is below the current ROIC(4.38%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.97%
ROE 4.53%
ROIC 4.38%
ROA(3y)12.18%
ROA(5y)9.5%
ROE(3y)17.23%
ROE(5y)14.16%
ROIC(3y)4.13%
ROIC(5y)4.98%

1.3 Margins

With an excellent Profit Margin value of 9.45%, COO belongs to the best of the industry, outperforming 85.03% of the companies in the same industry.
In the last couple of years the Profit Margin of COO has grown nicely.
COO's Operating Margin of 16.90% is amongst the best of the industry. COO outperforms 89.30% of its industry peers.
In the last couple of years the Operating Margin of COO has remained more or less at the same level.
Looking at the Gross Margin, with a value of 66.36%, COO is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
COO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.9%
PM (TTM) 9.45%
GM 66.36%
OM growth 3Y4.97%
OM growth 5Y-0.95%
PM growth 3Y-5.84%
PM growth 5Y8.19%
GM growth 3Y1.29%
GM growth 5Y0.36%

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COO is destroying value.
COO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

COO has an Altman-Z score of 4.11. This indicates that COO is financially healthy and has little risk of bankruptcy at the moment.
COO's Altman-Z score of 4.11 is fine compared to the rest of the industry. COO outperforms 72.73% of its industry peers.
The Debt to FCF ratio of COO is 13.91, which is on the high side as it means it would take COO, 13.91 years of fcf income to pay off all of its debts.
COO has a better Debt to FCF ratio (13.91) than 71.12% of its industry peers.
A Debt/Equity ratio of 0.33 indicates that COO is not too dependend on debt financing.
The Debt to Equity ratio of COO (0.33) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 13.91
Altman-Z 4.11
ROIC/WACC0.51
WACC8.66%

2.3 Liquidity

COO has a Current Ratio of 1.99. This is a normal value and indicates that COO is financially healthy and should not expect problems in meeting its short term obligations.
COO has a Current ratio of 1.99. This is in the lower half of the industry: COO underperforms 67.91% of its industry peers.
A Quick Ratio of 1.18 indicates that COO should not have too much problems paying its short term obligations.
COO's Quick ratio of 1.18 is on the low side compared to the rest of the industry. COO is outperformed by 69.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.18

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.63% over the past year.
COO shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.69% yearly.
EPS 1Y (TTM)15.63%
EPS 3Y3.78%
EPS 5Y3.69%
EPS Q2Q%19.88%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.85%

3.2 Future

COO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.70% yearly.
The Revenue is expected to grow by 6.27% on average over the next years.
EPS Next Y11.31%
EPS Next 2Y11.49%
EPS Next 3Y10.89%
EPS Next 5Y9.7%
Revenue Next Year7.61%
Revenue Next 2Y7.17%
Revenue Next 3Y6.4%
Revenue Next 5Y6.27%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

4

4. Valuation

4.1 Price/Earnings Ratio

COO is valuated rather expensively with a Price/Earnings ratio of 24.97.
Compared to the rest of the industry, the Price/Earnings ratio of COO indicates a rather cheap valuation: COO is cheaper than 83.42% of the companies listed in the same industry.
COO is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.83, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 22.43, which indicates a rather expensive current valuation of COO.
80.21% of the companies in the same industry are more expensive than COO, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.65, COO is valued at the same level.
Industry RankSector Rank
PE 24.97
Fwd PE 22.43

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, COO is valued a bit cheaper than 78.61% of the companies in the same industry.
COO's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. COO is cheaper than 69.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 97.25
EV/EBITDA 20.89

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COO does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of COO may justify a higher PE ratio.
PEG (NY)2.21
PEG (5Y)6.77
EPS Next 2Y11.49%
EPS Next 3Y10.89%

6

5. Dividend

5.1 Amount

With a yearly dividend of 0.02%, COO is not a good candidate for dividend investing.
COO's Dividend Yield is rather good when compared to the industry average which is at 1.62. COO pays more dividend than 89.84% of the companies in the same industry.
With a Dividend Yield of 0.02, COO pays less dividend than the S&P500 average, which is at 2.24.
Industry RankSector Rank
Dividend Yield 0.02%

5.2 History

On average, the dividend of COO grows each year by 10.52%, which is quite nice.
COO has been paying a dividend for at least 10 years, so it has a reliable track record.
COO has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.52%
Div Incr Years0
Div Non Decr Years15

5.3 Sustainability

COO pays out 0.42% of its income as dividend. This is a sustainable payout ratio.
COO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP0.42%
EPS Next 2Y11.49%
EPS Next 3Y10.89%

COOPER COS INC/THE

NASDAQ:COO (12/18/2024, 8:12:01 PM)

After market: 92.39 0 (0%)

92.39

-2.1 (-2.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap18.40B
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield 0.02%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 24.97
Fwd PE 22.43
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.21
PEG (5Y)6.77
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 4.53%
ROCE
ROIC
ROICexc
ROICexgc
OM 16.9%
PM (TTM) 9.45%
GM 66.36%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.99
Quick Ratio 1.18
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)15.63%
EPS 3Y3.78%
EPS 5Y
EPS Q2Q%
EPS Next Y11.31%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y